Choong Ang Vaccine Laboratory Co., Ltd.
Research Choong Ang Vaccine Laboratory Co., Ltd. (072020.KQ) on Bullrun: market cap KRW 83.31B, dividend yield 2.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker072020.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 83.31B
- Dividend yield2.2%
- Financial periodQ2 2026
- RevenueKRW 11.90B
- Net incomeKRW 1.29B
- Free cash flowKRW 4.35B
- Gross margin48.9%
Valuation Snapshot
latest market cap is KRW 83.31B; dividend yield is 2.2%.
Peer valuation comparison
Latest dividend yield is 2.22% versus a Healthcare sector median of 2.4% (7.5% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 83.31B | n/a | 2.2% | 200 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 200 KRW, yield 2.2%.
About Choong Ang Vaccine Laboratory Co., Ltd.
Choong Ang Vaccine Laboratory Co., Ltd. engages in the research, development, manufacturing, and sale of animal vaccines in South Korea, Asia, Africa, and the United States. It offers swine, poultry, cattle, canine, feline, wild boar, and raccoon vaccines under the SuiShot, PoulShot, BoviShot, CaniShot, and FeliShot brands. The company was founded in 1968 and is headquartered in Daejeon, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Choong Ang Vaccine Laboratory Co., Ltd.'s market cap?
Choong Ang Vaccine Laboratory Co., Ltd.'s market capitalization is KRW 83.31B.
Does Choong Ang Vaccine Laboratory Co., Ltd. pay a dividend?
Choong Ang Vaccine Laboratory Co., Ltd. has a dividend yield of 2.2%.
What does Choong Ang Vaccine Laboratory Co., Ltd. do?
Choong Ang Vaccine Laboratory Co., Ltd. engages in the research, development, manufacturing, and sale of animal vaccines in South Korea, Asia, Africa, and the United States. It offers swine, poultry, cattle, canine, feline, wild boar, and raccoon vaccines under the SuiShot, PoulShot, BoviShot, CaniShot, and FeliShot brands. The company was founded in 1968 and is headquartered in Daejeon, South Korea.